Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly EPS (Basic) of -$0.5 for Q1 2026, up 25.3% year-over-year from -$0.4 in Q1 2025, and down 2.68% quarter-over-quarter from -$0.49 in Q4 2025.
Powered by 
Analysis
Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.5 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 25.3% year-over-year to -$0.5; the TTM figure through Mar 2026 stood at -$1.77 (up 43.52% YoY), while the FY2025 annual figure was -$1.91, up 18.27% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.5, down from -$0.49 in the prior quarter.
- The five-year high for EPS (Basic) was $0.14 in Q1 2024, with the low at -$1.63 in Q2 2023.
- The 5-year median for EPS (Basic) is -$0.79 (2023), against an average of -$0.79.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 113.77% in 2024, then tumbled 575.63% in 2025.
- Zentalis Pharmaceuticals' EPS (Basic) stood at -$0.91 in 2022, then decreased by 2.25% to -$0.93 in 2023, then increased by 28.31% to -$0.67 in 2024, then climbed by 26.63% to -$0.49 in 2025, then decreased by 2.68% to -$0.5 in 2026.
- Business Quant data shows ZNTL's EPS (Basic) at -$0.5 in Q1 2026, -$0.49 in Q4 2025, and -$0.37 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 0.18 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.06 |
| 10 | Zentalis Pharmaceuticals | 283.52 Mn | 283.52 Mn | - | -0.59 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.59 |
| Mar 31, 2026 | -0.50 |
| Dec 31, 2025 | -0.49 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -1.24 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | -0.93 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | -1.63 |
| Mar 31, 2023 | -1.03 |
| Dec 31, 2022 | -0.91 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -1.23 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | -1.13 |
| Sep 30, 2021 | -0.24 |